Skip to content

Specimen Collection from Pregnant Women At Increased Risk for Fetal Aneuploidy

Down Syndrome | Fetal Aneuploidy

The specimen collection is designed for the purpose of the development of a noninvasive prenatal test for T21.

null

Participation Requirements

  • Sex:

    FEMALE

  • Eligible Ages:

    18 and up

Participation Criteria

Inclusion Criteria:

* pregnant between 10 and 22 weeks gestation
* 18 years of age or older
* provides signed and dated informed consent
* subject is at increased risk for fetal aneuploidy
* subject is willing to undergo a CVS and/or amniocentesis procedure for the purpose of genetic analysis
* subject agrees to provide the genetic results of the invasive procedure

Exclusion Criteria:

* Fetal demise at time of specimen sampling
* Previous sample donation under this protocol

Study Location

North York General Hospital
North York General Hospital
Toronto, Ontario
Canada

Contact Study Team

Primary Contact

Clare Gibbons

[email protected]
416 756-6788
IWK Health Centre
IWK Health Centre
Halifax, Nova Scotia
Canada

Contact Study Team

Backup Contact

Jo-Ann Brock, MD

Study Sponsored By
Sequenom, Inc.
Participants Required
More Information
Study ID: NCT01429389